Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.

Saved in:
Bibliographic Details
Title: Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.
Authors: Ji, Shiya1 (AUTHOR) jishiya@126.com, Chen, Xupeng1 (AUTHOR), Yu, Yebo2 (AUTHOR), Jia, Qiuping3 (AUTHOR), Zhang, Xingxing3 (AUTHOR), Gao, Zixin4 (AUTHOR)
Source: BMC Women's Health. 2/28/2025, Vol. 25 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14726874
DOI:10.1186/s12905-025-03612-7